These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 32008239)
1. Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III Trials. Guinn D; Wilhelm EE; Shoulson I Ther Innov Regul Sci; 2020 Jan; 54(1):232-239. PubMed ID: 32008239 [TBL] [Abstract][Full Text] [Related]
2. Prematurely ended phase III trials in Sweden during the years 2002-2008. Hedenmalm K; Johansson A; Bäckman K; Ohagen P Eur J Clin Pharmacol; 2011 Sep; 67(9):869-75. PubMed ID: 21399946 [TBL] [Abstract][Full Text] [Related]
3. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications. Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277 [TBL] [Abstract][Full Text] [Related]
4. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination. Williams RJ; Tse T; DiPiazza K; Zarin DA PLoS One; 2015; 10(5):e0127242. PubMed ID: 26011295 [TBL] [Abstract][Full Text] [Related]
5. Predictors of premature termination of cardiac surgery trials: insights from the Clinicaltrial.gov database. Cancelli G; Rossi CS; Dell'Aquila M; Mantaj P; Hirofuji A; Soletti G; Harik L; Cangut B; Al Zaghari T; Leith J; Falco G; Ibrahim M; Dimagli A; Rahouma M; Gaudino MFL Eur J Cardiothorac Surg; 2024 Aug; 66(2):. PubMed ID: 39133169 [TBL] [Abstract][Full Text] [Related]
6. Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry. Bernardez-Pereira S; Lopes RD; Carrion MJ; Santucci EV; Soares RM; de Oliveira Abreu M; Laranjeira LN; Ikeoka DT; Zazula AD; Moreira FR; Cavalcanti AB; Mesquita ET; Peterson ED; Califf RM; Berwanger O; Am Heart J; 2014 Aug; 168(2):213-9.e1. PubMed ID: 25066561 [TBL] [Abstract][Full Text] [Related]
7. Recruitment failure and futility were the most common reasons for discontinuation of clinical drug trials. Results of a nationwide inception cohort study in the Netherlands. van den Bogert CA; Souverein PC; Brekelmans CTM; Janssen SWJ; Koëter GH; Leufkens HGM; Bouter LM J Clin Epidemiol; 2017 Aug; 88():140-147. PubMed ID: 28487159 [TBL] [Abstract][Full Text] [Related]
8. Estimating the rate and reasons of clinical trial failure in urologic oncology. Stensland KD; DePorto K; Ryan J; Kaffenberger S; Reinstatler LS; Galsky M; Canes D; Skolarus TA; Moinzadeh A Urol Oncol; 2021 Mar; 39(3):154-160. PubMed ID: 33257221 [TBL] [Abstract][Full Text] [Related]
9. Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov. Lebensburger JD; Hilliard LM; Pair LE; Oster R; Howard TH; Cutter GR Clin Trials; 2015 Dec; 12(6):575-83. PubMed ID: 26085544 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the Frequency, Characteristics, and Reasons for Termination of Spine-related Clinical Trials. Caruana DL; Nam-Woo Kim D; Galivanche AR; David WB; Justen MA; Moushey AM; Sheth AH; Paranjpe MD; Grauer JN Clin Spine Surg; 2022 Aug; 35(7):E596-E600. PubMed ID: 35351841 [TBL] [Abstract][Full Text] [Related]
11. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M; J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993 [TBL] [Abstract][Full Text] [Related]
12. Discontinuation of surgical versus nonsurgical clinical trials: an analysis of 88,498 trials. Mouw TJ; Hong SW; Sarwar S; Fondaw AE; Walling AD; Al-Kasspooles M; DiPasco PJ J Surg Res; 2018 Jul; 227():151-157. PubMed ID: 29804847 [TBL] [Abstract][Full Text] [Related]
13. Results Reporting and Early Termination of Childhood Obesity Trials Registered on ClinicalTrials.gov. Wang X; Long Y; Yang L; Huang J; Du L Front Pediatr; 2022; 10():860610. PubMed ID: 35402346 [TBL] [Abstract][Full Text] [Related]
14. Low dissemination rates, non-transparency of trial premature cessation and late registration in child mental health: observational study of registered interventional trials. Vrljičak Davidović N; Tokalić R; Burilović E; Pejdo S; Marušić A; Singh S; Franić T Eur Child Adolesc Psychiatry; 2020 Jun; 29(6):813-825. PubMed ID: 31486894 [TBL] [Abstract][Full Text] [Related]
15. Premature termination of clinical trials in Spain: reasons, characteristics, and opportunities to improve. Filippi-Arriaga F; Boy RJ; Del Gobbo AD; Gallego AR Eur J Clin Pharmacol; 2023 Feb; 79(2):249-256. PubMed ID: 36525040 [TBL] [Abstract][Full Text] [Related]
16. Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors. Khunger M; Rakshit S; Hernandez AV; Pasupuleti V; Glass K; Galsky MD; Grivas P Oncologist; 2018 Dec; 23(12):1494-1499. PubMed ID: 30068783 [TBL] [Abstract][Full Text] [Related]
17. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials. Carlisle B; Kimmelman J; Ramsay T; MacKinnon N Clin Trials; 2015 Feb; 12(1):77-83. PubMed ID: 25475878 [TBL] [Abstract][Full Text] [Related]
18. Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency. Collignon O; Koenig F; Koch A; Hemmings RJ; Pétavy F; Saint-Raymond A; Papaluca-Amati M; Posch M Trials; 2018 Nov; 19(1):642. PubMed ID: 30454061 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the frequency, characteristics, and reasons for termination of shoulder- and elbow-related clinical trials. Caruana DL; Gouzoulis MJ; McLaughlin WM; Grauer JN J Shoulder Elbow Surg; 2022 Sep; 31(9):1922-1928. PubMed ID: 35398166 [TBL] [Abstract][Full Text] [Related]